Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions—An observational study in Nepal

Banstola NL, Hasker E, Mieras L, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2024; 18 (12) : 1-15.
Download PDF
Publication

Leprosy: Evidence supporting safe diagnosis and monitoring of contacts

Ferreira SMB, da Silva FV, Oliveira JSRD, et al. World Evidence-based Healthcare Day. 2024;
Download PDF
Publication

Anti‑phenolic glycolipid‑I seropositivity among household contacts of leprosy patients in Egypt

Salah EM, Khalil H, Moussa ME, et al. Springer Science and Business Media LLC. Archives of Dermatological Research. 2024;
Publication

Hanseníase: a importância do exame de contatos no controle epidemiológico - relato de caso

Nogueira França T, Machado Calil V, Silva Soares Untar V, et al. Faculdade de Medicina de Campos. Anais da Semana Científica da Faculdade de Medicina de Campos. 2024;
Publication

Sobreposição da hanseníase em redes de convívio domiciliar: gerações envolvidas, densidade de casos e perfis sociodemográfico e econômico em municípios do Norte e Nordeste do Brasil

Boigny RN, Souza EAD, Reis ADSD, et al. FapUNIFESP (SciELO). Cadernos Saúde Coletiva. 2024; 32 (1) : 1-15.
Download PDF
Publication

Models for predicting the risk of illness in leprosy contacts in Brazil: Leprosy prediction models in Brazilian contacts

de Alecrin ES, Martins MAP, de Oliveira ALG, et al. Wiley. Tropical Medicine & International Health. 2024;
Publication

Asymptomatic leprosy contacts present asymmetrical skin temperature in hands by infrared thermography

Sabino EFP, Fernandes Santos D, Eulálio Antunes D, et al. Lepra. Leprosy Review. 2024; 95 (2) : 1-10.
Download PDF
Publication

Meeting of Leprosy Programme Managers in the South-East Asia Region Kolkata, India, 11–13 April 2023

World Health Organization. Regional Office for South-East Asia . 2024;
Download PDF
Publication

Community-Based Intervention for Active Detection and Provision of Single-Dose Rifampicin Post-Exposure Prophylaxis to Household Contacts of Leprosy in Bolivia

Baptista Mora A, Ortuño-Gutiérrez N, Zurita Paniagua D, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2024; 9 (5) : 1-12.
Download PDF
Publication

Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration.

Minter A, Medley G, Hollingsworth DT. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024; 78 (Supplement_2) : S169-S174.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 2
  • Next page ››
Subscribe to Contacts / Contact tracing

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD